Johnson & Johnson (JNJ)

Financing Cash Flow

-$15.39B

Quarterly · Period ending: · USD

JNJ logo

JNJ Financing Cash Flow

Latest reported-$15.39B
JNJ Quarterly Cash from Financing (-$85.00M → -$15.39B)
High-resolution chart · PNG

JNJ financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Some observations are unavailable. The chart shows available values; missing observations are not treated as zero.

Johnson & Johnson Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
-15,387,000,000
530,000,000
-1,369,000,000
-8,927,000,000
-5,665,000,000
10,422,000,000
-1,340,000,000
-9,882,000,000
7,544,000,000
546,000,000
-4,655,000,000
-11,317,000,000
-5,991,000,000
6,138,000,000
1,700,000,000
-3,925,000,000
-2,261,000,000
-4,385,000,000
-3,436,000,000
-2,207,000,000
-3,279,000,000
-5,125,000,000
-5,644,000,000
4,196,000,000
-357,000,000
-4,315,000,000
-4,072,000,000
-3,893,000,000
-4,534,000,000
-5,516,000,000
-6,389,000,000
-3,477,000,000
-2,674,000,000
-5,970,000,000
-3,537,000,000
-2,069,000,000
-1,917,000,000
-150,000,000
-3,464,000,000
-3,445,000,000
-1,464,000,000
-178,000,000
-3,291,000,000
-1,825,000,000
-2,503,000,000
-3,227,000,000
-619,000,000
-5,716,000,000
-2,868,000,000
-3,057,000,000
1,182,000,000
-4,519,000,000
-1,977,000,000
-777,000,000
-1,471,000,000
-14,505,000,000
-3,403,000,000
-1,183,000,000
-756,000,000
-2,232,000,000
-639,000,000
-825,000,000
2,606,000,000
-1,699,000,000
-2,065,000,000
-3,822,000,000
1,078,000,000
-3,242,000,000
-2,060,000,000
132,000,000
-4,470,000,000
-1,696,000,000
-188,000,000
-1,110,000,000
-1,848,000,000
-1,230,000,000
-1,535,000,000
-1,085,000,000
2,303,000,000
-3,454,000,000
-3,794,000,000
-1,164,000,000
-824,000,000
-1,318,000,000
-1,160,000,000
-1,219,000,000
-1,407,000,000
-1,169,000,000
-1,069,000,000
-1,503,000,000
-2,046,000,000
-1,820,000,000
1,012,000,000
-1,009,000,000
-1,062,000,000
-1,674,000,000
-2,054,000,000
-2,163,000,000
-2,061,000,000
-1,144,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.